Vivere Oncotherapies

About Vivere Oncotherapies

Vivere Oncotherapies is focused on developing next-generation cancer therapies to activate the immune system to detect and destroy cancer cells in cold tumors. Their mission, reflected in their name 'Vivere' meaning 'to live,' is to create life-saving treatments through innovative engineering and collaborative science, aiming for transformative breakthroughs in oncology.

Products & Services

Cancer Immunotherapy Platform:A proprietary bioengineering platform designed to create safe, targeted, and effective cancer therapies that enhance delivery to cold tumors, based on over 25 years of research.

Specialties

Cancer Immunotherapy Bioengineering Gene Therapy Viral Vector Engineering Immuno-Oncology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Unknown T: - FT: Unknown	A: 10000000 MR: - FA: > $10M FAN: 10000000	D: 2026-01-13 FD: 2026-01-13	5 investors

Unknown Latest

2026-01-13

$10.0M

5 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Melissa Kotterman

CEO

A

Adam Schieferecke

Co-founder; Head of Research

H

Hyuncheol Lee

Co-founder; Head of Nonclinical Development

D

David Schaffer

Co-founder; President

J

John Dueber

Co-founder; Scientific Advisor

W

Wanichaya Noiwangklang

Co-founder; Head of Operations

View 11 more team members with Pro

Unlock Full Team Directory

Recent News